MicroRNAs as Biomarkers in First Episode Schizophrenia

Abroad (travel likely)Recruiting

Conditions

Schizophrenia Disorder · Schizophreniform Disorder · Schizoaffective Disorder · Psychosis Not Otherwise Specified (NOS)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Zucker Hillside Hospital, Glen Oaks, New York, United States
Contact: Study coordinator (Nicole Montgomery) · NMontgomery@northwell.edu · 9494869390

Study leads

Juan Gallego, MD
Principal Investigator
Northwell Health

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Decision-Making in Schizophrenia: A Combined Neuroimaging and Experience Sampling Study

Schizophrenia · Schizoaffective Disorder · Control Subjects

Abroad (travel likely)Recruiting

Piscataway, United States

Magnetic Seizure Therapy for Schizophrenia - Trial

Treatment Resistant Schizophrenia · Schizophrenia · Schizoaffective Disorder

Abroad (travel likely)Recruiting

Vancouver, Canada · Toronto, Canada

Biomarkers in Clozapine-responding Schizophrenia

Schizophrenia · Psychosis

Abroad (travel likely)RecruitingPHASE4

Glostrup Municipality, Denmark

Switching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia

Schizophrenia · Schizoaffective Disorder

Abroad (travel likely)RecruitingPHASE4

Toronto, Canada